Primo Medical Group Organizes Golf Tournament to Support The Ocular Immunology and Uveitis Foundation
Oct 06, 2015, 11:00 ET
STOUGHTON, Mass., Oct. 6, 2015 /PRNewswire/ -- Primo Medical Group announced today that it organized a golf tournament held on September 2, 2015 which successfully raised over $190,000.00 to support The Ocular Immunology and Uveitis Foundation (OIUF). The 501c3 non-profit foundation is based in Massachusetts. Uveitis is a rare ocular inflammatory disease responsible for up to 20% of all blindness. It is also the leading cause of blindness in young girls. Its mission is to train doctors who diagnose and treat uveitis, provide patient education and research for a cure.
"Primo Medical Group is pleased to give back to the community by being the lead sponsor of this event, It is important for our employees, vendors, customers, family and friends to know how grateful we are for their participation and support," said company CEO Steven Tallarida. "The tournament brought together over 240 individuals comprised of golfers and volunteers on a beautiful day at The Pine Hills Golf Course in Plymouth, MA. We couldn't be happier with the turnout and with the generous support of all the attendees," said Andrea Patisteas, Senior Executive VP at Primo Medical Group, whose daughter Mia Resendes has been treated for uveitis since December 2010.
Guest speakers included Dr. C. Stephen Foster, founder of OIUF and Massachusetts Eye Research & Surgery Institution, 16 year old Mia Resendes, and Jay Jay French, founder of Twisted Sister, whose daughter also has uveitis.
The Golf Tournament was originally created because of Mia's desire to support the work that has benefitted her. " I cannot tell you how happy I feel when I see so many people coming together to help the foundation that conducts research, training and education for uveitis," said Mia. For more information on The Ocular Immunology and Uveitis Foundation please visit their website at www.uveitis.org
About Primo Medical Group
Primo Medical Group is a leader in the development, manufacture and assembly of medical devices and precision machined components. Established in 1953, Primo Medical Group is a privately held company with 4 facilities in Massachusetts. Primo Medical is ISO 13485:2003 and ISO 9001:2008 certified, JPAL and FDA approved.
For more information, please visit www.primomedicalgroup.com.
SOURCE Primo Medical Group